ECHA guidance on CLP
The CLP Regulation ensures that the hazards presented by chemicals are clearly communicated to workers and consumers in the European Union through classification and labelling of chemicals.
In most of the cases, suppliers need to decide on the classification of a substance or mixture. This is called self-classification.
Suppliers must label a substance or mixture contained in packaging according to CLP before placing it on the market either when:
- A substance is classified as hazardous
- A mixture contains one or more substances classified as hazardous above a certain threshold.
Harmonised Classification and Labelling
Certain situations require that the classification of a substance is harmonised and made obligatory at Community level to ensure an adequate risk management throughout the European Community.
Alternative chemical name in mixtures
Suppliers who are concerned about disclosing the full composition of a mixture, on the label or in the safety data sheet, can request the use of an alternative chemical name for a substance to protect the confidential nature of their business, and in particular, their intellectual property rights.
The Classification & Labelling (C&L) Inventory is a database that will contain basic classification and labelling information on notified and registered substances received from manufacturers and importers.
Harmonised information is submitted to the appointed bodies in the Member State and is used for emergency health response (the Poison Centres).
Consolidated versions of the Regulation.
The role of testing in CLP
If no data are available, ecotoxicological and toxicological tests should be performed that comply with requirements. Information on alternative methods to animal testing, testing for human health and environmental hazards and for physical hazards.
The range of actions that national authorities initiate to verify the compliance of the duty holders with REACH and CLP Regulations.
Substances of potential concern
Substances with certain hazardous properties need to be identified and subsequently processed using relevant regulatory steps to make sure that the risks associated with their use are properly addressed.